Acella Settlement With Thyroid Patients Gets Early Court Nod

A settlement between Acella Pharmaceuticals LLC and patients who said they overpaid for a thyroid medication that didn’t have the correct amount of active ingredient was preliminarily approved by a federal judge.

Acella will reimburse out-of-pocket costs up to $50 per class member for patients with dispensed prescriptions for NP Thyroid between May 12, 2018, and April 30, 2021, according to the proposed settlement agreement. Class members with expenditures less than $10 can recover $10.

The company voluntarily recalled the medication on April 29, 2021, after testing revealed low potency in 35 batches.

Judge Richard W. Story, of the US ...